Cutaneous follicle center lymphoma, spleen
ICD-10 C82.67 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, spleen.
Cutaneous follicle center lymphoma (CFCL) is a subtype of non-Hodgkin lymphoma that primarily affects the skin and is characterized by the proliferation of B-cells in the follicle center. When CFCL involves the spleen, it indicates a more systemic manifestation of the disease. Patients may present with skin lesions, lymphadenopathy, and splenomegaly. The disease is often indolent, but it can transform into a more aggressive form. Staging is crucial, typically following the Ann Arbor classification, which assesses the extent of lymphatic involvement. B-symptoms, including fever, night sweats, and weight loss, may be present and are indicative of a more advanced disease state. Treatment protocols may include localized therapies such as radiation for skin lesions, systemic therapies like chemotherapy, immunotherapy, or targeted therapies depending on the stage and symptoms. Regular monitoring and follow-up are essential to manage the disease effectively and to adjust treatment as necessary.
Detailed clinical notes on staging, treatment plans, and follow-up care.
Diagnosis and management of CFCL, treatment response evaluation.
Need for interdisciplinary communication regarding treatment plans.
Photographic evidence of skin lesions, biopsy results, and treatment responses.
Initial diagnosis of skin lesions, management of cutaneous symptoms.
Documentation of skin involvement and response to topical therapies.
Used for biopsy of skin lesions suspected to be CFCL.
Pathology report and clinical notes detailing the lesion.
Dermatology and oncology must collaborate on biopsy results.
Common symptoms include skin lesions, lymphadenopathy, splenomegaly, and B-symptoms such as fever, night sweats, and weight loss.
